DERPHARTOX - Key Persons
Dr. Elliott obtained his Master's in Toxicology and his Ph.D. from Surrey University, Guilford, UK. He moved to Erasmus University, Rotterdam in 1981, where he researched the role of eicosanoids in immune-inflammatory reactions, before moving to TNO (Netherlands Institute for Applied Research) in 1988. During his time at TNO Dr. Elliott developed a number of alternative in vitro models for investigating acute interactions between chemical agents and the skin and humanized models for investigating chronic interactions. Derphartox was established in 2001 by Dr. Elliott with the aim of exploiting these models for pharmaceutical research.
Job Titles:
- Senior Science Consultant
Prof. dr. Das obtained his Master's in Clinical Biochemistry at the University of Sheffield and finished his Ph.D. at the University of London, UK. He has held several international postdoctoral positions and has spend most of his professional career as Associate Professor at the Departments of Dermatology & Pathology where he formed his research group on Tissue Specific Immune Reactivity with a focus on Dermato-Pathological Research. He retired in 2006 but still continues to work on various research themes in collaboration with various internationally famous institutes and is an active honorary member of the Department Pathology (Neuropathology Division) of the Academic Medical Center/University of Amsterdam, Department of Infection & Immunity/Leiden University Medical Center, School of Immunity and Infection/Colleges of Medical and Dental Sciences/University of Birmingham, Institute Lauro Souza Lima/Bauru/Sao Paulo/Brazil and Immunodeficiency and Inflammation/Institute Pediatrics/University of Brescia/Italy.